Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Congenital Heart Block
Immunoadsorption: potential treatment for mothers with autoimmune-associated CHB
August 4th, 2005
Immunoadsorption is a potential treatment for mothers with autoimmune-associated congenital heart block (CHB). According to recent research from Germany, "Autoimmune-associated congenital heart block is a rare complication of pregnancy in mothers with Anti-Ro/SSA antibodies (SSA-abs), resulting in fetal myocarditis, atrioventricular block, hydrops fetalis, and/or intrauterine fetal death. As these antibodies are supposed to be directly involved in the pathogenesis of CHB, their removal should be associated with an improved clinical course." "Extracorporeal immunoadsorption (IA) is the most efficient method to remove IgG-immunoglobulins like SSA-abs...
Source: Women's Health Weekly (2005-08-04)
|
